Journal of pain and symptom management
-
J Pain Symptom Manage · Apr 2023
Creating a dedicated palliative care team for ICU Spanish speaking patients in response to COVID-19.
The Latinx population faced higher rates of infection and severe illness during the COVID-19 pandemic, resulting in an increased need for palliative care services. ⋯ The creation of a focused clinical program targeting a historically marginalized population offered opportunity for early palliative care intervention in clinical care for Spanish-speaking patients. This underscores the need for Spanish-language concordant palliative care to improve serious illness care, and end-of-life care, by providing continuity of care, spiritual care, and ICU team support.
-
J Pain Symptom Manage · Apr 2023
Standard Naloxone Prescribing for Palliative Care Cancer Patients on Opioid Therapy: A Single-Site Quality Improvement Pilot to Assess Attitudes and Access.
Limited data exist on when to offer naloxone to cancer patients on opioid therapy. ⋯ Opioid safety education and naloxone prescribing can be done quickly and is well-received by clinicians and patients.
-
J Pain Symptom Manage · Apr 2023
Just-in-Time Decision Making: Preliminary Findings of a Goals of Care Rapid Response Team.
The COVID-19 pandemic placed the issue of resource utilization front and center. Our comprehensive cancer center developed a Goals of Care Rapid Response Team (GOC RRT) to optimize resource utilization balanced with goal-concordant patient care. ⋯ GOC RRT consultations were feasible and associated with care limitation. Adherence to core team participation was fair.
-
J Pain Symptom Manage · Apr 2023
Nationwide Study of Continuous Deep Sedation Practices Among Pediatric Palliative Care Teams.
Palliative sedation practices evolved in France when the Claeys-Leonetti law passed in 2016 authorized patient-requested continuous deep sedation (CDS) until death. Its implementation in the pediatric setting is less frequently encountered and can pose several clinical and ethical challenges for health care teams and families. ⋯ Managing patient-requested CDS in pediatrics is challenging due to its rarity, multi-factorial refractory symptoms and drug tolerance despite polytherapy. Few recommendations exist to guide CDS practice for pediatricians. Further studies investigating pediatric CDS practices across various cultural and legal settings, refractory symptom management and specific pharmacology are warranted.